Pharmaceutical Executive-02-28-2006

The high court’s decision on this licensing dispute could have far-reaching implications for patent negotiations, legal experts say.

An analysis of Merck’s clinical trial data for Singular (montelukast) indicates that obese people may respond to asthma treatments differently than lean people. A University of Michigan professor explains his recently published paper.